Investigating genetic factors influencing heart, lung, blood, and sleep disorders.
Official title: NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ - 2024 TASK ORDER
Funded at New York Genome Center · NIH-11212395 · Data updated 2026-11-12
This study is looking for people to help us understand how our genes might affect health issues like heart, lung, blood, and sleep problems, so we can find better ways to care for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York Genome Center NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 23, 2024 |
| Project end | September 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,160,471 |
| NIH project number | 75N92023D00016-0-759202400001-1 |
| Project ID | NIH-11212395 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with a family history of heart, lung, blood, or sleep disorders, as well as those currently diagnosed with these conditions.
✕Less likely to help
Patients without any genetic predisposition or current diagnosis related to heart, lung, blood, or sleep disorders may not benefit from this research.
What this research studies
This research focuses on generating high-quality genomic data to identify risk factors for various health conditions, including heart, lung, blood, and sleep disorders. The New York Genome Center will utilize advanced sequencing technologies, including whole genome sequencing and RNA sequencing, to analyze genetic information. By participating in large-scale genomic studies, this project aims to enhance our understanding of how genetic variations contribute to these diseases, ultimately leading to improved patient care.
Why it matters
Potential benefit: If successful, this research could lead to better identification of genetic risk factors, enabling more personalized and effective treatments for patients with heart, lung, blood, and sleep disorders.
How similar studies have gone: Previous research initiatives have successfully utilized similar genomic sequencing approaches to uncover genetic factors associated with various diseases, indicating a promising potential for this project.
Where this research is happening
-
New York Genome Center
New York, United States Active
Researchers
- Principal investigator: Rizaj, Khulangoo — New York Genome Center
- Study coordinator: Rizaj, Khulangoo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.